Greg B. Scott - President & Founder, ChinaBio® LLC
Jason (Gang) Jin, MD, PhD - CEO, ShanghaiBio Corporation
09:10 - 09:30
Introduction to the SEED Business Plan Competition
SEED – Scientists to Entrepreneurs, Education and Development, is a life sciences and healthcare business plan competition created to develop and foster a community of scientists, healthcare professionals and entrepreneurs and create a platform for commercialization of life sciences and healthcare innovation in China. Created by Roche, OrbiMed and McKinsey, SEED will provide aspiring entrepreneurs with coaching and feedback from the leading players in China’s investment community and healthcare industry. The top prize will be over RMB 300,000.
Stella Xu, PhD - Executive Director, Roche Global Pharma Partnering
09:30 - 10:10
How to Develop a Drug: From Bench to Commercialization
Starting a company can appear to be a daunting chanllenge to most scientists, but personal and financial rewards can be tremendous. SEED can help scientists take this first big step by providing a platform for emerging entrepreneurs to move their business concept from idea to reality. Specific examples of successful biotech companies will be given to illustrate how technology can move from the lab to the market.
Rajesh Parekh, PhD - Director, Head of Asia Healthcare Practice, McKinsey & Company
Frank Grams, PhD - Executive Director, Roche Global Pharma Partnering
Panel 1: How to Attract Funding - What VCs Really Want
Venture capitalists are the life blood of life science companies, which require significant capital to reach the market. Positioning a company to secure VC funding can be a challenge, especially in these times when capital is tight. Hear from VCs exactly what they look for, and how a company can attract their attention and money.
To increase a company's competitveness and keep investors happy, an entrepreneur must keep adding value to their company from multiple perspectives ranging from IP portfolio, strategic alliances and partnerships to product offerings and R&D. This panel examines the key value creation dimensions and increasing value in each.
Lan Kang, MBA - Client Partner, Korn/Ferry (Shanghai) Human Capital Consulting Co., Ltd.
Frank Grams, PhD - Executive Director, Roche Global Pharma Partnering
Jonathan Wang, PhD, MBA - Senior Managing Director, OrbiMed Asia
15:30 -16:00
How to “Quan” VCs’ Money
Sun Tzu said, “Know yourself and your enemy, and you will win 100% of the battles.”In the battle of winning financing from VCs, an entrepreneur needs to know the VCs he or she is dealing with.What do the VCs care about in the company and the financing?How to present your business to appear more attractive to the VCs?OrbiMed Asia’s Jonathan Wang will tell you his insider’s views to help you answer these questions.
Jonathan Wang, PhD, MBA - Senior Managing Director, OrbiMed Asia